Emerging Immunotherapeutic Agents for the Treatment of Bladder Cancer
AUAUniversity31 Mar 2017

Emerging Immunotherapeutic Agents for the Treatment of Bladder Cancer

The goal of this knowledge-based activity is to improve clinicians' understanding of current immunotherapeutic agents for the treatment of bladder cancer and to increase their ability to improve patient outcomes and the management of adverse events. Educational grants provided by the following corportations: AstraZeneca, Bristol-Myers Squibb, Genentech, Merck

Episoder(425)

Rotating On The Urology Service  Facts And Strategy For Medical Students

Rotating On The Urology Service Facts And Strategy For Medical Students

Moderator: Seth Cohen, MD Panelists: Gina Badalato, MD Kathleen Kieran, MD Kyle Zuniga (MS4) Vincent D'Andrea (MS4)

5 Feb 20201h 9min

2019 Presidential Address: Urologic Research: Why is it So Important to Us

2019 Presidential Address: Urologic Research: Why is it So Important to Us

2019 AUA Annual Meeting Presidential Address Robert Flanigan, MD, FACS Loyola University Chicago Stritch School of Medicine

29 Jan 202021min

AUA2018 Presidential Address: Artificial Intelligence, Robotics and the Future of Urology

AUA2018 Presidential Address: Artificial Intelligence, Robotics and the Future of Urology

2018 AUA Annual Meeting Presidential Address J. Brantley Thrasher, MD, FACS Department of Urology, University of Kansas Health System

21 Jan 202019min

AUA2017 Presidential Address: Urology: A Personal Perspective

AUA2017 Presidential Address: Urology: A Personal Perspective

2017 AUA Annual Meeting Presidential Address Urology: A Personal Perspective Richard K. Babayan, MD, FACS

14 Jan 202023min

AUA2016 Presidential Address: US Healthcare Reform: Past, Present, and Future

AUA2016 Presidential Address: US Healthcare Reform: Past, Present, and Future

2016 AUA Annual Meeting Presidential Address William F. Gee, MD Lexington, KY

8 Jan 202020min

Targeted Therapies In Renal Cell Carcinoma

Targeted Therapies In Renal Cell Carcinoma

Co-Host: Jay Raman, MD, FACS At the conclusion of these activities, participants will be able to: 1. Review the mechanisms of action, efficacy, and safety of currently available targeted treatment of...

24 Des 201933min

Sequencing Of Agents And Combination Of Treatment Options For Bladder Cancer

Sequencing Of Agents And Combination Of Treatment Options For Bladder Cancer

Co-Host: Yair Lotan, MD At the conclusion of these activities, participants will be able to: 1. Evaluate treatment plans including the sequencing and combination of treatment options for individual p...

18 Des 201937min

Sequencing Of Agents And Combination of Treatment Options for Renal Cell Carcinoma

Sequencing Of Agents And Combination of Treatment Options for Renal Cell Carcinoma

Co-Host: Brian M. Shuch, MD At the conclusion of these activities, participants will be able to: 1. Describe a patient-specific treatment plan that optimizes the use of targeted and immunological age...

11 Des 201927min

Populært innen Fakta

fastlegen
dine-penger-pengeradet
relasjonspodden-med-dora-thorhallsdottir-kjersti-idem
treningspodden
rss-strid-de-norske-borgerkrigene
foreldreradet
jakt-og-fiskepodden
hverdagspsyken
rss-sunn-okonomi
merry-quizmas
sinnsyn
gravid-uke-for-uke
tomprat-med-gunnar-tjomlid
rss-kunsten-a-leve
smart-forklart
fryktlos
rss-mann-i-krise-med-sagen
hagespiren-podcast
rss-impressions-2
dopet